Home / News / India News / Article /
Russias Sputnik V COVID-19 vaccine claimed to be 95 per cent effective
Updated On: 24 November, 2020 12:00 AM IST | | IANS
The Russian vaccine uses two different vectors based on the human adenovirus, rather than using one and the same vector for two dose
Listen to this article :
This file handout picture provided by the Russian Direct Investment Fund shows the vaccine against the COVID-19 coronavirus disease, developed by the Gamaleya Research Institute of Epidemiology and Microbiology. Picture/ Russian Direct Investment Fund / A
Russia-s Sputnik V vaccine has been found to be more than 95 per cent effective against Covid-19 in the second interim analysis of Phase 3 clinical trial data, its developers said on Tuesday.
The analysis was based on data from volunteers obtained 42 days after the first dose -- which corresponds with 21 days after the second dose, Gamaleya National Research Centre for Epidemiology and Microbiology of the Russian Health Ministry and Russian Direct Investment Fund RDIF, said.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT